Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1974-10-21
1976-06-01
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
A61K 31425
Patent
active
039610675
ABSTRACT:
Several benzenesulfonylurea compounds derived from 4-methyl-5-thiazolecarboxylic acid have been prepared by reacting 4-[2-(4-methyl-5-thiazolecarboxamido)ethyl]benzenesulfonamide with an appropriate organic isocyanate or a trisubstituted urea equivalent thereof. The sulfonylureas so obtained are useful in therapy as oral hypoglycemic agents. 1-Cyclohexyl-3-{4-[2-(4-methyl-5-thiazolecarboxamido)ethyl]benzenesulfonyl }urea represents a preferred embodiment.
REFERENCES:
patent: 3755587 (1973-08-01), Plumpe et al.
Kuhla Donald E.
Sarges Reinhard
Wiedermann Hans E.
Pfizer Inc.
Waddell Frederick E.
LandOfFree
Composition comprising a benzenesulfonylurea hypoglycemic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition comprising a benzenesulfonylurea hypoglycemic agent , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition comprising a benzenesulfonylurea hypoglycemic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2403524